Literature DB >> 8072122

Immunohistochemical detection of p53 protein in human prostatic cancer.

R P Henke1, E Krüger, N Ayhan, D Hübner, P Hammerer, H Huland.   

Abstract

Tissue sections from 73 radical-prostatectomy specimens were studied immunohistochemically for the presence of p53 protein. In seven specimens numerous tumor cells showed a strong nuclear immunostaining. An additional 27 revealed a more discrete and focal accumulation of p53 protein. Comparison of the pathologic characteristics of the p53-negative and -positive groups showed that the presence of p53 protein closely correlated with more advanced tumor stages (p < 0.00001), with higher primary (p = 0.0004), combined (p < 0.0001) and worst (p < 0.0001) Gleason grades, and with larger total (p = 0.0001) and high-grade (p < 0.0001) tumor volumes. No staining was found in areas of benign hyperplasia or in well-differentiated tumor zones. Our results suggest that the accumulation of p53 protein to immunohistochemically detectable concentrations is not a feature of low-grade cancer. This finding implies that abnormal p53 accumulation might be involved in the process of prostatic cancer progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072122     DOI: 10.1016/s0022-5347(17)32571-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Molecular staging of prostate cancer in the year 2007.

Authors:  Thorsten Schlomm; Andreas Erbersdobler; Martina Mirlacher; Guido Sauter
Journal:  World J Urol       Date:  2007-03-02       Impact factor: 4.226

2.  Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy.

Authors:  Herbert Augustin; Peter G Hammerer; Markus Graefen; Jüri Palisaar; Fedor Daghofer; Hartwig Huland; Andreas Erbersdobler
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-26       Impact factor: 4.553

3.  Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.

Authors:  Christian P Meyer; Jens Hansen; Katharina Boehm; Derya Tilki; Firas Abdollah; Quoc-Dien Trinh; Margit Fisch; Guido Sauter; Markus Graefen; Hartwig Huland; Felix K H Chun; Sascha A Ahyai
Journal:  World J Urol       Date:  2016-06-03       Impact factor: 4.226

4.  Nuclear iASPP may facilitate prostate cancer progression.

Authors:  E V Morris; L Cerundolo; M Lu; C Verrill; F Fritzsche; M J White; G N Thalmann; C S ten Donkelaar; I Ratnayaka; V Salter; F C Hamdy; X Lu; R J Bryant
Journal:  Cell Death Dis       Date:  2014-10-23       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.